Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |